PainChek (ASX:PCK)

Company Profile

PainChek® – giving a voice to those who cannot reliably verbalise their pain.

PainChek ®Adult app is the world’s first regulatory-cleared medical device for the assessment of pain, enabling best-practice pain management for people living with pain in any environment, from those who cannot reliably self-report their pain, those who can, and for those whose ability to self-report their pain fluctuates.

The PainChek® app is available on smartphones and tablets and combines PainChek’s AI pain assessment tool, which intelligently automates the multidimensional pain assessment process.

Globally, PainChek® has attained regulatory clearance as a medical device in Australia, Canada, the European Union, New Zealand, Singapore, Malaysia, and the United Kingdom, and currently in the final stage review with FDA for De Novo regulatory clearance in the USA.

PainChek® has contracts with over 1,900 aged care facilities, with more than 12,000,000 digital pain assessments conducted to date, and is used and trusted by thousands of nurses, carers, and clinicians.

Using PainChek®, facilities can:

  • Ensure greater consistency, continuity, and diagnostic certainty in pain assessment and management by decreasing subjectivity and removing unintentional assessor bias
  • Streamline the pain assessment process for time-poor carers, with access to the PainChek® tool, the NRS, pain trends, and charting in one solution
  • Simplify record-keeping and documentation to demonstrate compliance and support funding claims, with all historical pain assessment data in one place

PainChek® Infant app identifies and detects six facial action units indicative of pain in infants aged one month to 12 months and is now commercially available on the App Store for home use by parents to better manage pain with their infants.

 

KEY PEOPLE

Philip Daffas

Philip Daffas

CEO & Managing Director

Philip is a highly accomplished global business leader and people manager with an international career spanning more than 25 years with leading blue-chip healthcare corporates and novel technology start-up companies.

Philip has held senior global business leadership positions in Europe, US and Australia. He has been instrumental in building businesses, growing market share and developing extensive high-level customer relationships in each sector.

Philip’ roles in Australia have included VP Global Marketing at Cochlear and General Management with Roche Diagnostics and Bio-Rad Laboratories, and CEO of Applied Physiology, an Australian start up software company in the intensive care monitoring sector.

Philips’ earlier experience was gained in Europe with market leaders such as IVAC infusion systems and Shiley cardiopulmonary products. He subsequently joined Boehringer Mannheim, initially in the UK managing their diagnostics business and subsequently was promoted to Global Marketing Director in the Diabetes Care business based in Mannheim, Germany.

In 1997 Philip joined Cochlear in the UK as the European Sales and Marketing Manager and subsequently was promoted to the VP Global Marketing role based in Sydney, Australia.

Iain McAdam

Iain McAdam

Chief Financial Officer

Iain joined PainChek in March 2021 as CFO and leads all the finance and risk functions.

Iain has over 20 years finance and transformational change experience within listed high growth multinational software and services companies and a commercially valuable combination of expertise across sales and ‘quote to cash’ revenue operations.   ACA and ASCPA qualified, Iain was previously based in the UK at Micro Focus, a global enterprise software provider.  Prior to that, other companies included iSoft, a healthcare IT provider and eServGlobal.

Iain said “I am excited to be in a highly committed team delivering growth in a global technology business with the goal to make PainChek the universal pain assessment system used by healthcare professionals in all locations”.

Iain is based in Sydney, where he enjoys family time and cycling.

Andrew Hoggan

Andrew Hoggan

Head of Operations

Andrew is a Psychologist, management consultant, business leader and executive coach.

As a registered Psychologist, Andrew has worked in both Australia and the U.K providing counselling within the homeless and prison communities. Shifting to corporate Psychology, Andrew specialised in change, culture and leadership and over the course of 13 years has led transformations including restructures, IT projects and culture programs across the public and private sectors.

Andrew’s passion for working in Aged Care began in the role of General Manager at Mirus Australia, a consultancy supporting Aged Care providers to achieve financial sustainability. Since then he has co-founded initiatives that strive to improve leadership capability across the Aged Care sector.

In his spare time, Andrew runs an organic truffle farm and is passionate about motivating organisations and individuals to learn, engage and participate in positive change.

RELATED STOCKHEAD STORIES